ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NITE Nightstar Therapeutics Plc ADS

25.41
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nightstar Therapeutics Plc ADS NASDAQ:NITE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 25.41 18.50 25.41 0 01:00:00

Knight Capital Group To Host Annual Analyst And Investor Meeting Monday, November 2, 2009

29/10/2009 11:30am

PR Newswire (US)


Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Nightstar Therapeutics Plc ADS Charts.
Live webcast and conference call of presentation available for all interested parties JERSEY CITY, N.J., Oct. 29 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) today announced it will host its annual analyst and investor meeting on Monday, November 2, 2009. The meeting will begin at 10:30 a.m. Eastern Time (ET) and conclude at approximately 12:00 p.m. ET. A live webcast and conference call of the presentation will be available for all interested parties. To access the webcast, go to http://www.knight.com/investorrelations/webcasts.asp on Knight's website. Individuals that wish to access the meeting by telephone may do so by dialing 800-500-0920 (domestic callers) or 719-457-2653 (international callers) and entering confirmation code 6728424. Following the meeting, the webcast will be archived at http://www.knight.com/. A replay of the conference call will be available by dialing 888-203-1112 (domestic callers) or 719-457-0820 (international callers) and entering confirmation code 6728424. About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is a global capital markets firm that provides market access and trade execution services across multiple asset classes to buy- and sell-side firms. Knight's hybrid market model features complementary electronic and voice trade execution services in global equities and fixed income as well as foreign exchange, futures and options. The firm is consistently ranked as the leading source of off-exchange liquidity in U.S. equities. Knight also provides capital markets services to corporate issuers. Knight is headquartered in Jersey City, NJ with a growing global presence across North America, Europe and the Asia-Pacific region. For more information, please go to http://www.knight.com/. Certain statements contained herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict including, without limitation, risks associated with the costs, integration, performance and operation of businesses recently acquired, or that may be acquired in the future, by the Company and risks related to the costs and expenses associated with the Company's exit from the Asset Management business. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein. Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the U.S. Securities and Exchange Commission (SEC), including, without limitation, those detailed under the headings "Certain Factors Affecting Results of Operations" and "Risk Factors" in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. This information should also be read in conjunction with the Company's Consolidated Financial Statements and the Notes thereto contained in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Communications, Marketing & Investor Relations, +1-201-557-6954, , or Kara Fitzsimmons, Director, Media Relations, +1-201-356-1523, , or Jonathan Mairs, Vice President, Corporate Communications, +1-201-356-1529, , all for Knight Capital Group, Inc. Web Site: http://www.knight.com/

Copyright

1 Year Nightstar Therapeutics Plc ADS Chart

1 Year Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart